Basic Science of Wound Healing
Basic Science of Wound Healing
Basic Science of Wound Healing
Pauline Beldon
Abstract
Wound healing is a complicated process, dependent on the patients
underlying health and nutritional status and also upon the clinicians
ability to recognize stages of wound healing. For appropriate management, an understanding of the basic physiology of wound healing is
necessary.
Haemostasis
Within seconds of skin injury, vasoconstriction occurs to reduce
blood loss. As blood spills into the wound area, platelets come
into contact with and adhere to the wall of the injured blood
vessels and to the exposed collagen within the extracellular
matrix. This triggers platelets to release cytokines, growth factors
and numerous pro-inflammatory mediators resulting in platelet
aggregation and triggering the intrinsic and extrinsic coagulation
pathways, leading to fibrin clot formation. The clot seals the
disrupted blood vessels, preventing further blood loss.1 The clot
is sustained by the rapid intravascular accumulation of microvesicular tissue factor (TF) as microvesicles from white cells are
attracted to the platelet surface.
Growth factors produced by the platelets initiate the healing
cascade. Platelet-derived growth factor (PDGF) initiates the
chemotaxis of neutrophils and macrophages, smooth muscle
cells and fibroblasts, while also stimulating mitogenesis of
smooth muscle cells and fibroblasts.
Transforming growth factor-beta (TGF-b) attracts macrophages into the wound area and stimulates them to produce
additional cytokines, including fibroblast growth factor (FGF),
PDGF, tumour necrosis alpha (TNFa) and interleukin-1 (IL-1). In
addition TGF-b further enhances the fibroblast and smooth
muscle chemotaxis and modulates the expression of collagen and
collagenase. The purpose of PDGF and TGF-b is to stimulate
a response form the matrix to produce cells in preparation for the
rapid deposition of new connective tissue to rebuild the extracellular matrix. The clinical picture of haemostasis is clearly
demonstrated by wounds such as skin graft donor site wounds
which heal by regeneration (Figure 1).
Inflammation
Tissue injury and the activation of the coagulation cascade
stimulate the release of vascoactive cytokines such as prostaglandins, histamine and other amines from the granules released
by mast cells as a response to injury, which results in increased
local vasodilation and capillary permeability. The vessels
become more permeable, allowing the migration of monocytes
into the wound bed. Serous fluid also leaks into the wound bed
and the surrounding tissue, creating oedema. These are part of
the characteristic signs of inflammation. The patient is likely to
complain of increasing pain 24 hours after wounding or surgery
(hence the need for good analgesic provision).
During the period of inflammation neutrophils accumulate
within the wound area, their primary role being to act as
a wound cleanser. They are initially attracted to the wound area
by various chemotactic agents released from bacteria. Once in
the wound, they ingest the bacteria via phagocytosis. Neutrophils
SURGERY 28:9
409
BASIC SCIENCE
Figure 3 Sloughy wound bed due to the clearance of debris, bacteria and
non-viable connective tissue by neutrophils.
SURGERY 28:9
410
BASIC SCIENCE
restored. As new blood vessels intrude into the wound environment the oxygen tension rises and oxygen binds onto the HIF,
blocking its activity which in turn leads to decreased production
of VEGF.
The process of angiogenesis is interdependent on the
production of a new extracellular matrix (ECM) which acts as
a scaffold to support the newly formed blood vessels.
The predominant cell responsible for the formation of the
ECM is the fibroblast, these are attracted into the wound bed by
cytokines produced by macrophages and then transformed into
wound fibroblasts which have decreased proliferative behaviour,
but increased collagen production behaviour.
Collagen synthesis to form the new ECM is a multi-layered
process.
During the initial phase of wound healing (haemostasis) the
fibrin clot supports the migration of cells into the wound. This
fibrin matrix is gradually replaced by material comprised mainly
of fibronectin and hyaluronic acid, both of which promote cell
migration and proliferation. Fibroblasts attach to the provisional
fibrin matrix and begin collagen production. The early, so-called
type 3 collagen comprises approximately 30% of granulation
tissue and does not contribute to the tensile strength of the
wound. Hence any wound healing by secondary intention
requires supportive dressings during this stage (e.g., an abdominal support belt for the patient with a dehisced abdominal
wound). As collagen matures, type 3 collagen is converted to
type 1 collagen, normally found in dermal tissue.
In wounds healing by primary intention collagen synthesis
peaks at day 5e6, although collagen synthesis and re-modulation
of collagen continue for several months. Clearly only a small
amount of collagen is required to heal the deficit in a sutured
wound and by day 5e6 it should be possible to palpate a healing
ridge under the intact suture line, formed by the deposition of
collagen.4 Wounds in which this healing ridge is absent may be
at risk of dehiscence. Commonly there are underlying complications (e.g. anaemia or past history of smoking, low oxygen
tension). Vitamin C deficiency can lead to reduced hydroxyproline which gives collagen molecules stabilization and aids the
tensile strength of the wound.
SURGERY 28:9
Epithelialization
In this final stage of visible wound healing, epithelial cells
migrate from the wound edges to resurface the wound defect.
411
BASIC SCIENCE
resulting in abnormal scar formation, whether keloid or hypertrophic scarring. If the patient is severely malnourished then the
rate of collagen synthesis is delayed and can lead to late wound
breakdown.
Conclusion
Wound healing is a well-coordinated process, provided the
individual is nutritionally robust, haemodynamically well and
biochemically stable. However in those patients with wounds
healing by secondary intention it is not unusual to have at least
one complicating factor (commonly malnuturition) which needs
to be addressed. Clinicians need to recognize the processes and
factors involved in normal wound healing.
A
REFERENCES
1 Verhamme P, Hoylaerts MF. Haemostasis and inflammation: two of
a kind? Thromb J 2009; 7: 1e3.
2 Diegleman RF, Evans MC. Wound healing: an overview of acute, fibrotic
and delayed healing. Front Biosci 2004; 9: 283e9.
3 Beldon P. Recognising wound infection. Nurs Times 2001; 97: 3e4.
4 Hunt TK, Van Winkle W. Normal repair. In: Hunt TK, Dunphy JE, eds.
Fundamentals of wound management. New York: Appleton-CenturyCrofts, 1997.
5 Hunter JE, Teot L, Horch R, Banwell PE. Evidence-based medicine:
vacuum-assisted closure in wound care management. Int Wound J
2007; 4: 256e69.
6 Berry DP, Harding KG, Stanton MR, Jasani B, Ehrlich HP. Human wound
contraction: collagen organization, fibroblasts, and myofibroblasts.
Plast Reconstr Surg 1998; 102: 124e34.
7 Rudolph R. Location of the force of wound contraction. Surg Gynaecol
Obstet 1979; 148: 547e51.
8 Kuhn MA, Smith PD, Hill DP, et al. In vitro fibroblast populated
collagen lattices are not good models on in vivo clinical wound
healing. Wound Repair Regen 2000; 8: 270e6.
9 Winter GD. Formation of the scab and the rate of re-epithelialisation in
the skin of the young domestic pig. Nature 1962; 193: 293e4.
Remodelling phase
This may extend to a year or more, during which fibroblasts
regulate the process of wound matrix breakdown by matrix
metalloproteinases (MMPs) and synthesis of new extracellular
matrix. This slow process increases the tensile strength of the
wound, but scar tissue is never more than 80% of the tensile
strength in unwounded tissue. Occasionally during the process of
remodelling an imbalance may occur, during which the process
of matrix degradation and that of synthesis are disrupted
SURGERY 28:9
412